We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
+6.34%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$2.62B
AUM Growth
+$368M
Cap. Flow
+$229M
Cap. Flow %
8.75%
Top 10 Hldgs %
18.1%
Holding
2,638
New
585
Increased
1,008
Reduced
426
Closed
81

Sector Composition

Rank Sector Weight
1 Technology 8.21%
2 Financials 4.98%
3 Healthcare 4.3%
4 Consumer Discretionary 3.17%
5 Industrials 3.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLS icon
1826
WisdomTree International SmallCap Dividend Fund
DLS
$1.08B
$10.5K ﹤0.01%
152
BJ icon
1827
BJs Wholesale Club
BJ
$12.3B
$10.5K ﹤0.01%
+127
New +$10.7K
AEM icon
1828
Agnico Eagle Mines
AEM
$90.5B
$10.5K ﹤0.01%
130
EL icon
1829
Estee Lauder
EL
$32B
$10.4K ﹤0.01%
104
+91
+700% +$8.63K
DFIN icon
1830
Donnelley Financial Solutions
DFIN
$1.16B
$10.3K ﹤0.01%
+157
New +$10.2K
IXJ icon
1831
iShares Global Healthcare ETF
IXJ
$4.18B
$10.3K ﹤0.01%
105
ARES icon
1832
Ares Management
ARES
$30.9B
$10.3K ﹤0.01%
+66
New +$9.58K
AL
1833
DELISTED
Air Lease Corp
AL
$10.3K ﹤0.01%
+227
New +$10.4K
AMRC icon
1834
Ameresco
AMRC
$1.36B
$10.2K ﹤0.01%
270
TNL icon
1835
Travel + Leisure Co
TNL
$4.7B
$10.2K ﹤0.01%
222
+165
+289% +$7.29K
RWO icon
1836
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.3B
$10.2K ﹤0.01%
215
-500
-70% -$22.6K
CDP icon
1837
COPT Defense Properties
CDP
$4.21B
$10.2K ﹤0.01%
+336
New +$9.57K
HGTY icon
1838
Hagerty
HGTY
$1.39B
$10.2K ﹤0.01%
1,000
IMTM icon
1839
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.27B
$10.1K ﹤0.01%
250
SLQD icon
1840
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
$10.1K ﹤0.01%
200
-100
-33% -$4.99K
KOS icon
1841
Kosmos Energy
KOS
$1.48B
$10.1K ﹤0.01%
2,500
MGPI icon
1842
MGP Ingredients
MGPI
$375M
$10.1K ﹤0.01%
+121
New +$10K
PAG icon
1843
Penske Automotive Group
PAG
$14.2B
$10.1K ﹤0.01%
62
+32
+107% +$5.1K
BCRX icon
1844
BioCryst Pharmaceuticals
BCRX
$2.4B
$10K ﹤0.01%
1,322
+822
+164% +$6.25K
CAE icon
1845
CAE Inc. Common Shares
CAE
$8.74B
$9.9K ﹤0.01%
+528
New +$9.46K
TGTX icon
1846
TG Therapeutics
TGTX
$7.62B
$9.89K ﹤0.01%
423
TFX icon
1847
Teleflex
TFX
$5.98B
$9.89K ﹤0.01%
+40
New +$9.34K
VYX icon
1848
NCR Voyix
VYX
$1.14B
$9.88K ﹤0.01%
728
-68
-9% -$909
ROSC icon
1849
Hartford Multifactor Small Cap ETF
ROSC
$62.5M
$9.84K ﹤0.01%
225
RM icon
1850
Regional Management Corp
RM
$303M
$9.81K ﹤0.01%
300

Similar funds

Geneos Wealth Management's Q3 2024 Portfolio in Review

As of Q3 2024, Geneos Wealth Management held 2,638 positions worth $2.62B, up 16% from $2.25B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Geneos Wealth Management deployed $229M of net new capital in Q3 2024, opening 585 new positions and adding to 1,008 existing holdings. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 104,319 shares worth $7.39M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, down from 8.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $11.9M trimmed.

  • Geneos Wealth Management's largest Q3 2024 buy was iShares Core MSCI International Developed Markets ETF: 104,319 shares worth $7.39M.
  • Geneos Wealth Management added most to PGIM Ultra Short Bond ETF in Q3 2024, an estimated $9.4M increase.
  • Geneos Wealth Management's biggest Q3 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $11.9M.
  • Geneos Wealth Management fully exited iShares MSCI Germany ETF in Q3 2024, selling an estimated $2.37M.
  • Geneos Wealth Management's ten largest holdings make up 18% of its $2.62B portfolio in Q3 2024.
  • Geneos Wealth Management opened 585 new positions and closed 81 in Q3 2024.
  • Geneos Wealth Management's portfolio value rose 16% quarter-over-quarter to $2.62B.

Based on Geneos Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.